Garuda - Garba Rujukan Digital

p-Index From 2021 - 2026

1.665

P-Index

This Author published in this journals

All Journal Indonesian Journal of Applied Sciences Jurnal Kedokteran Brawijaya International Journal of Integrated Health Sciences Majalah Kedokteran Bandung Althea Medical Journal Global Medical and Health Communication Sari Pediatri Paediatrica Indonesiana Jurnal Kesehatan Vokasional Jurnal Gizi Klinik Indonesia Jurnal Pendidikan dan Pelayanan Kebidanan Indonesia (Indonesian Journal of Education and Midwifery Care) Jurnal Ilmiah Kebidanan Indonesia (Indonesian Midwifery Scientific Journal) Jurnal Medika Cendikia (e-Journal) Journal of Early Childhood Education (JECE) Berita Kedokteran Masyarakat Journal Research Midwifery Politeknik Tegal

Kusnandi Rusmil

Departemen Ilmu Kesehatan Anak Fakultas Ilmu Kedokteran Universitas Padjadjaran Bandung

Author-ID : 366212

Religion Humanities Biochemistry, Genetics & Molecular Biology Chemistry Computer Science & IT Dentistry Education Environmental Science Health Professions Immunology & microbiology Library & Information Science Medicine & Pharmacology Nursing Public Health

Published : 51 Documents Claim Missing Document

Claim Missing Document

Articles

1 2 3 4 5

Booster Vaksinasi Hepatitis B Terhadap Anak yang Non Responder Kusnandi Rusmil; Eddy Fadlyana; Novillia S Bachtiar
Sari Pediatri Vol 12, No 2 (2010)
Publisher : Badan Penerbit Ikatan Dokter Anak Indonesia (BP-IDAI)

Latar belakang. Berbagai penelitian terhadap respons imun setelah imunisasi hepatitis B dengan menggunakan vaksin monovalen dari plasma maupun yang berasal dari teknik DNA rekombinan menunjukkan antara 5%-15% tidak memberikan respons (non-responder) atau kurang memberikan respons (hypo-responder) Center of Disease Control merekomendasikan terhadap anak yang tidak mempunyai tingkat proteksi antibodi (anti-Hbs) setelah mendapat imunisasi dasar, perlu diberikan 3 kali suntikan rangkaian ke-2. Setelah rangkaian ke-2 imunisasi Hepatitis B tersebut maka 30%-50% diantaranya akan mempunyai kadar yang protektif.Tujuan. Penelitian bertujuan mengeksplorasi lebih mendalam mengenai manfaat pemberian vaksinasi rangkaian kedua pada anak hipo dan non responder sebagai salah satu data yang dapat dipergunakan strategi menghadapi masalah hepatitis B di Indonesia.Metode. Penelitian dilakukan terhadap 144 anak yang telah melaksanakan imunisasi dasar hepatitis B secara lengkap (3 kali) yang merupakan bagian uji klinis vaksin pentavalen (DPT/hepatitis B/Hib). Enam bulan setelah mengetahui kadar anti-Hbs hasil uji klinik pentavalen dilakukan pemberian imunisasi rangkaian ke-2 pada anak-anak hipo/non-responder.Hasil. Sebelas anak mempunyai kadar anti-Hbs <10 mIU/ml (non/hypo responder terhadap vaksinasi Hepatitis B). Terhadap kesebelas anak tersebut dilakukan pemeriksaan kadar anti-Hbs setelah 6 bulan pemberian imunisasi hepatitis B-3, didapatkan 3 anak (27,2%) mengalami peningkatan sehingga mempunyai kadar anti-Hbs >10 mIU/ml, 8 orang anak (72,2%) mempunyai kadar <10 mIU/ml. Pada 8 anak tersebut dilakukan imunisasi rangkaian ke-2 hepatitis B sebanyak 3 kali. Setelah mendapat rangkaian ke-2 imunisasi Hepatitis B, kedelapan subjek (100%) mencapai kadar protektif (>10 mIU/ml).Kesimpulan. Pemberian 3 dosis standar hepatitis B dapat digunakan untuk memberikan kekebalan pada anak sehat dengan hypo/non responder.

Stunting Determinant on Toddler Age of 12–24 Months in Singaparna Public Health Center Tasikmalaya Regency Erwina Sumartini; Dida Akhmad Gurnida; Eddy Fadlyana; Hadi Susiarno; Kusnandi Rusmil; Jusuf Sulaeman Effendi
Global Medical & Health Communication (GMHC) Vol 7, No 3 (2019)
Publisher : Universitas Islam Bandung

Stunting is a physical growth failure condition signed by height based on age under −2SD. The research goal is knowing the dominant factor associated with stunting on toddler age of 12–24 months in the working area of Singaparna Public Health Center Tasikmalaya regency. The research applies to the cross-sectional design of gender, weight, exclusive breastfeeding history, completeness immunization, and clinically healthy variables, while case-control is for nutrition intake variable. The sample was a total sampling of 376 toddlers, then 30 for case and control group with the simple random method from December 2017 to February 2018. The instrument is a questionnaire, food frequency questionnaire (FFQ), and infantometer. Data analyzed in several ways; univariable, bivariable with chi-square, and multivariable with logistic regression. Research result shows stunting prevalence was 22.5%, next pertain factor of stunting are gender (POR=0.564, 95% CI=0.339–0.937, p value=0.011), exclusive breastfeeding giving history (POR=1.46, 95% CI=1.00–2.14, p value=0.046), and clinically health (POR=1.47, 95% CI=1.00–2.16, p value=0.044). Moreover, dominant factor were gender (OR=0.56, 95% CI=0.339–0.937, p value=0.027) and clinically health (OR=1.68, 95% CI=1.022–2.771, p value=0.041). Thus, gender and clinical health are stunting determinant factors. Children’s health should increase to create maximum growth. DETERMINAN STUNTING PADA ANAK USIA 12–24 BULAN DI PUSKESMAS SINGAPARNA KABUPATEN TASIKMALAYAStunting merupakan kondisi kegagalan pertumbuhan fisik yang ditandai dengan tinggi badan menurut usia berada di bawah −2SD. Penelitian ini bertujuan mengetahui faktor determinan stunting pada anak usia 12–24 bulan di wilayah kerja Puskesmas Singaparna Kabupaten Tasikmalaya. Penelitian menggunakan desain cross-sectional untuk variabel jenis kelamin, berat badan lahir, riwayat ASI eksklusif, kelengkapan imunisasi, dan sehat secara klinis, sedangkan desain case-control untuk variabel asupan nutrisi. Pengambilan sampel secara total sampling sejumlah 376 anak, selanjutnya diambil 30 anak untuk kelompok kasus dan kontrol dengan metode random sederhana periode Desember 2017 hingga Februari 2018. Instrumen menggunakan kuesioner, food frequency questionaire (FFQ), dan infantometer. Analisis data dilakukan secara univariabel, bivariabel dengan chi-square, dan multivariabel dengan regresi logistik. Hasil penelitian menunjukkan prevalensi stunting sebesar 22,6%, faktor yang berhubungan dengan stunting di antaranya jenis kelamin (POR=0,564; IK95%=0,339–0,937; p=0,011), riwayat pemberian ASI eksklusif (POR=1,46; IK95%=1,00–2,14, p=0,046), dan sehat secara klinis (POR=1,47; IK95%=1,00–2,16; p=0,044). Faktor dominan yang berhubungan dengan stunting adalah jenis kelamin (OR=0,56; IK95%=0,339–0,937; p=0,027) dan sehat secara klinis (OR=1,68; IK95%=1,022–2,771; p=0,041). Jenis kelamin dan sehat secara klinis merupakan faktor determinan stunting. Kesehatan anak perlu ditingkatkan untuk menciptakan pertumbuhan anak yang maksimal.

The Differences in Maternal Compliance in Completing Basic Immunization between Two Groups Ita Susanti; Dewi Marhaeni Diah Herawati; Eddy Fadlyana; Herry Herman; Kusnandi Rusmil; Firman Fuad Wirakusumah
Global Medical & Health Communication (GMHC) Vol 8, No 3 (2020)
Publisher : Universitas Islam Bandung

Immunization programs are implemented in Indonesia since 1956. Although the government has established a complete basic immunization program for infants aged 0–12 months, there are still more than 1.4 million child deaths in the world each year due to various infectious diseases. The diseases can be prevented by immunization. Low basic immunization coverage in infants is related to parental non-compliance in fulfilling primary immunization. The purpose of this study was to measure the differences in maternal compliance in completing basic immunization in two groups. Samples are a group of mothers provided with Maternal Child Health (MCH) book and special booklet, and another group provided with MCH book only. This study used a quasi-experiment design with quantitative methods with a sample of 76 respondents chosen by simple random sampling—this research conducted in August–October 2017 in Pir Batee Puteh Health Center, West Woyla district. The results indicate that there were differences in maternal compliance in completing basic immunization in mothers with MCH book and special booklet to mothers with only MCH book. Immunization health education interventions based on the MCH book and special booklet can improve the mother's compliance in completing the baby's basic immunization. PERBEDAAN KEPATUHAN IBU DALAM MELENGKAPI IMUNISASI DASAR ANTARA DUA KELOMPOKProgram imunisasi mulai dilaksanakan di Indonesia sejak tahun 1956. Meskipun pemerintah telah menetapkan program imunisasi dasar lengkap pada bayi usia 0–12 bulan, masih terdapat lebih dari 1,4 juta kematian anak di dunia setiap tahun karena berbagai penyakit menular yang pada dasarnya dapat dicegah dengan imunisasi. Cakupan imunisasi dasar yang rendah pada bayi berkaitan dengan ketidakpatuhan orangtua dalam memenuhi kelengkapan imunisasi dasar. Tujuan penelitian ini adalah mengukur perbedaan kepatuhan ibu dalam memenuhi kelengkapan imunisasi dasar pada dua kelompok. Sampel adalah kelompok ibu yang diberikan buku Kesehatan Ibu dan Anak (KIA) dan booklet, serta kelompok ibu yang diberikan buku KIA saja. Penelitian ini menggunakan desain quasy-experiment dan metode kuantitatif dengan sampel 76 responden yang dipilih secara simple random sampling. Penelitian dilakukan pada Agustus–Oktober 2017 di wilayah kerja Puskesmas Pir Batee Puteh, Kecamatan Woyla Barat. Hasil penelitian menunjukkan bahwa terdapat perbedaan kepatuhan ibu dalam memenuhi kelengkapan imunisasi dasar pada ibu yang diberikan buku KIA dan booklet dengan ibu yang hanya diberikan buku KIA. Intervensi pendidikan kesehatan imunisasi berdasar atas buku KIA dan booklet dapat meningkatkan pengetahuan dan kesadaran ibu tentang pentingnya imunisasi pada bayi sehingga meningkatkan kepatuhan ibu dalam melengkapi imunisasi bayinya.

Reliability of the Indonesian version of the School-Years Screening Test for Evaluation of Mental Status-Revised as a cognitive screening tool for children Ferriandis Harsono; Purboyo Solek; Kusnandi Rusmil
Paediatrica Indonesiana Vol 56 No 3 (2016): May 2016
Publisher : Indonesian Pediatric Society

Background Developmental and behavioral problems are among the most common conditions of childhood. These problems affect 12âˆ’16% of children in the United States and 13âˆ’18% of children in Indonesia. Early detection of developmental deficits among children requires clinicians to screen with accurate tools. Cognitive function screening in children has been increasingly used in many clinical and educational settings. The School-Years Screening Test for Evaluation of Mental Status-Revised (SYSTEMS-R) is becoming a widely-used, reliable, and valid cognitive screening tool for children aged 4âˆ’15 years. Prior to our study, there was no Indonesian language version of the SYSTEMS-R.Objective To determine the reliability of the Indonesian translation of the SYSTEMS-R.Methods A cross-sectional study was conducted in children aged 4âˆ’15 years who understood the Indonesian language and did not have neurologic or communication impairments. Data were analysed to determine reliability (internal consistency and inter-rater reliability) of the Indonesian version of SYSTEMS-R. Internal consistency was determined using Cronbachâ€™s alpha formula. Internal consistency is a reflection of inter-item correlation and item-to-total correlation. Inter-rater reliability was determined using the Bland-Altman method.Results This study was conducted on 133 children aged 4âˆ’15 years in a kindergarten, elementary, junior high, and senior high school in Bandung. The Indonesian version of SYSTEMS-R had significant internal consistency (Cron bachâ€™s alpha 0.936âˆ’0.941), and the scores obtained by two raters had good agreement (difference within mean + 1.96 SD).Conclusion The Indonesian version of SYSTEMS-R is reliable for use as a cognitive screening tool for Indonesian children. [Paediatr Indones. 2016;56:149-54.].

Obesity and academic performances in adolescents Nina Herlina; Julistio TB Djais; Kusnandi Rusmil
Paediatrica Indonesiana Vol 53 No 1 (2013): January 2013
Publisher : Indonesian Pediatric Society

Background Adolescence is a phase of dynamic developmentin human life, marked by rapid physical growth, in addition tomental, emotional, and social development. Adolescent obesityhas been related to metabolic disease, in addition to psychologicaldisorders, which may lead to a negative impact on academicperformances.Objective To assess academic performances in adolescents withobesityMethods A cross-sectional study was conducted in Junior HighSchool No. 14 in Bandung from December 2010 to July 2011.Subjects were aged 12 to 14 years, and were divided into two groups:obese or good nutritional status. Statistical analysis using Fisher'sexact test was performed to assess the association of obesity andacademic performances. T-test was used to compare subjects' meanmathematics and English performances in the two groups.Results There were 24D students who met the inclusion criteria.Since there were 40 obese subjects in the first group, we randomizedthe remaining students to obtain 40 subjects with good nutritionalstatus for the second group. Best academic performances inmathematics and English was obtained mostly by subjects in thegood nutrition group (38/40 and 39/40, respectively). Statisticalanalysis revealed a significant association of lower performances inmathematics (mean difference -2.8; 95%CI -5 to -0.6; P=0.043)and English (mean difference -1.9; 95%CI -3.5 to -0.2; P=0.001)to obesity. We also found a significant association of bettermathematics (P=0.001) and English performances (P=0.004)to the father's occupation. Additional English lessons were notassociated with higher English performances in the obese group(mean difference 0.2; 95%CI -2.9 to 3 .2; P=0.885).Conclusion Obese adolescents tend to have poorer academicperformances compared to those with good nutritional status.

Safety and immunogenicity of the DTP/HB /Hib combination vaccine: phase I study Kusnandi Rusmil; Eddy Fadlyana; Novilia Sjafri Bachtiar; Hadyana Hadyana
Paediatrica Indonesiana Vol 53 No 6 (2013): November 2013
Publisher : Indonesian Pediatric Society

Background The World Health Organization (WHO) hasrecommended the introduction ofhepatitis B (HB) and Haemophilusinfluenza type b (Hib) vaccines into routine childhood vaccinationprograms. A new diptheria/tetanus/pertussis (DTP) /hepatitis B/Hibpentavalent combination vaccine has been developed.Objective To evaluate the safety and immunogenicity of a newcombination DTP/HB/Hib liquid vaccin e in infants.Met hods An open-label, uncontrolled, prospective interventionphase I study was con ducted on 30 healthy infants aged 6- 11weeks. Each subject received 3 doses of DTP/HB/Hib vaccine,formulated by Bio Fanna, 0.5 mL intramuscularly at the leftanterolateral thigh region using a 25-gauge n eedle of 25 mmlength . Subjects were followed for 1 month after administration ofeach vaccine dose to evaluate its safety, while serum anti-diphteria,tetanus, HB, Hib, and per tussis antibodies were measured priorto the l '' dose and 1 month after the Jtd dose.Results Among 30 vaccinated subjects, 18 infants had fever within24 hours after the first vaccination. Most cases of fever were mildin intensity and resolved within 24 hours. No other systemic orlocal reactions, or serious adverse events were observed in oursubjects during the study. The immunogenicity results after Jtdvaccine dose showed that the geometric mean titer of the antipolyribosylribitolphosphate (PRP) antibody levels increasedsignificantly from 0.0041Î¼,g/mL to 4.3 7 Î¼,g/mL after vaccination,and most infants h ad a fourfo ld or greater rise in antibody levelsover their pre-injection levels . All subjects who received DTP/HB/Hib liquid vaccine had seropro tective antibodies againsttetanus, diphtheria,a and hepatitis B, while 29/30 infants hadseroprotective antibodies against pertussis.Conclusion This new diphtheria/tetanus/pertusis/hepatitis B/Hibcombination vaccine has excellent safety profile and antibodyresponses in infants. These results encourage further clinicalevaluation in phase II.

The occurrence of pulmonary hypertension in patients with thalassemia major Hasan Basri; Armijn Firman; Kusnandi Rusmil; Eddy Fadlyana
Paediatrica Indonesiana Vol 43 No 5 (2003): September 2003
Publisher : Indonesian Pediatric Society

Background The life of patients with thalassemia major dependson blood transfusions, while repeated blood transfusions may causeadverse effects such as iron deposition in various organs, includ-ing heart and lungs, which eventually increases the pulmonaryarterial pressure.Objective This study was proposed to know the occurrence ofpulmonary hypertension in patients with thalassemia major, mea-sured by echocardiography in the Thalassemia Clinic, Departmentof Child Health, Medical School, Padjadjaran University/HasanSadikin Hospital, Bandung.Methods A descriptive cross-sectional study was carried outon 30 patients with thalassemia major, aged 10-14 year-old whoreceived repeated blood transfusions. The study was conductedfrom April to May 2002. Subjects were examined right after ablood transfusion completed and the pulmonary arterial pres-sure was assessed using Dopplerâ€“echocardiography and 2-Dechocardiography.Results Twenty two out of 30 subjects showed pulmonary hyper-tension, with pulmonary arterial pressure ranged between 32.3 to46.2 mmHg. According to the age group, pulmonary hypertensionwas found in 12 out of 17 subjects aged 10-12 years old and 10out of 13 subjects aged 13-14 years old.Conclusion The occurrence of pulmonary hypertension in patientswith thalassemia major at Hasan Sadikin Hospital was 22/30 andseemed to increase with the age of the patients

Immunogenicity and safety of a trivalent inactivated influenza vaccine Eddy Fadlyana; Kusnandi Rusmil; Novilia Sjafri Bachtiar; Rachmat Gunadi; Hadyana Sukandar
Paediatrica Indonesiana Vol 51 No 1 (2011): January 2011
Publisher : Indonesian Pediatric Society

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.14238/pi51.1.2011.22-8

Background Trivalent inactivated influenza vaccines (TIV) containing antigens of two influenza A strains, A(H1N1) and A(H3N2), and one influenza B strain, are the standard {onnulation for influenza prevention. The vaccines must be updated annually to provide optimal protection against the predicted prevalent strains for the next influenza season.Objective To assess the immunogenidty and safety of the inactivated influenza vaccine (FlubioÂ®) in adolescents and adults, 28 days after a single dose.Methods In this experimental, randomized, single-blind, bridging study, we included 60 healthy adolescents and adults. A single, 0.5 mL dose was administered intramuscularly in the deltoid muscle of the left ann. Blood samples were obtained before and 28 days after immunization. Standardized hemagglutination inhibition (HI) test was used to assess antibody response to influenza antigens.Results From January to February 2010, a total of 60 adolescents and adults enrolled in the study, but two participants did not provide the required blood samples. One hundred percent of the subjects had an anti-influenza titer â‰¥ 1:40 HI units to all three strains, A/Brisbane/59/2007 (H1N1), A/Uruguay/716/2007 (H3N2), and B/Brisbane/60/2008 (P=1.000) after immunization. The Geometric Mean Titers (GMT) after immunization increasedfor all strains: A/Brisbane, 76.4 to 992.7, A/Uruguay, 27.6 to 432.1, and B/Brisbane, 19.9 to 312.7. Twenty eight days after immunization, we found a 4 times increase in antibody titers in 75.8% of the subjects for A/Brisbane, 84.5% for A/Uruguay, and 77.6% for B/Brisbane. We also observed that 100% of seronegative subjects converted to seropositive for all 3 strains. All vaccines were well-tolerated. There were no serious adverse events reported during the study.Conclusion In adolescents and adults, the FlubioÂ® vaccine was immunogenic and safe.

The immunogenicity and safety of the new, Indonesian DTwP-HB-Hib vaccine compared to the DTwP/HB vaccine given with the Hib vaccine Novilia Sjafri Bachtiar; Kusnandi Rusmil; Sunarjati Sudigdoadi; Cissy B Kartasasmita; Hadyana Hadyana
Paediatrica Indonesiana Vol 57 No 3 (2017): May 2017
Publisher : Indonesian Pediatric Society

Background Haemophilus influenzae type b (Hib) causes infection with predominant manifestations of pneumonia, meningitis, and other invasive diseases, occurring primarily in children aged under 2 years, particularly in infants.Â The World Health Organization (WHO) and Indonesian Technical Advisory Group for Immunization recommend to include the Hib vaccine into the national immunization program. The newly developed DTwP-HB-Hib combination vaccine is anticipated to be the preferred choice for Hib vaccine introduction; it is efficient, simple, and has higher coverage.Objective To evaluate the immunogenicity and safety of a new, combined Bio Farma DTwP-HB-Hib vaccine, compared to the registered Hib monovalent vaccine given simultaneously with the local DTwP-HB vaccine, when used as the primary vaccination of Indonesian infants.Methods A prospective, randomized, open-label, phase II study was conducted on the DTwP-HB-Hib vaccine compared to the Hib (registered) vaccine given simultaneously with the DTwP-HB vaccine, in Bandung from July 2011 to January 2012. Infants were serially vaccinated at 6-11, 10-15, and 14-19 weeks. Serological assessments were done prior to the first vaccine dose and 28 days after the third dose. Safety was assessed from the time of first injection until 1 month after the last injection.Results Of 220 healthy infants enrolled, 211 completed the study, with 105 receiving the combined vaccine and 106 the two separate vaccines. All vaccines were well tolerated. No differences in rates of local and systemic reactions were seen between the two methods of administration. No serious adverse events were considered to be related to the vaccines. In the DTwP-HB-Hib primary-vaccination group, at least 98% of the infants reached protective levels of antibodies (seropositivity) against the antigens employed in the vaccines while 96% in the control group.Conclusion The DTwP-HB-Hib combined vaccine is immunogenic and safe, as well as comparable to the Hib vaccine given simultaneously with to the DTwP-HB vaccine.

The quantity and quality of anti-PRP induced by the new Indonesian DTwP-HB-Hib vaccine compared to the Hib vaccine given with the DTwP-HB vaccine Novilia Sjafri Bachtiar; Kusnandi Rusmil; Sunarjati Sudigdoadi; Hadyana Sukandar; Rini Mulia Sari; Cissy B. Kartasasmita
Paediatrica Indonesiana Vol 57 No 5 (2017): September 2017
Publisher : Indonesian Pediatric Society

Background A phase II study of DTwP-HB-Hib vaccine compared to Hib (monovalent) vaccine given simultaneously with DTwP-HB vaccine has been done following the success of phase I study in infants, where the new DTwP-HB-Hib has excellent safety profiles and antibody responses in infants.Objective To evaluate the titer (quantity), avidity, and bactericidal capacity (quality of anti-polyribosylribitol phosphate/anti-PRP), of a new combined Bio Farma DTwP-HB-Hib (pentavalent) vaccine, compared to the Hib monovalent vaccine given simultaneously with the DTwP-HB vaccine (DTwP-HB+Hib).Methods The study was a prospective, randomized, open label, phase II trial. Subjects aged 6-11 weeks were allocated according to the randomization list. The pentavalent group received the DTwP-HB-Hib vaccine, while the monovalent group received the Hib monovalent and DTwP-HB vaccines separately. Immunizations were given in three doses with 28-day intervals. Blood specimens were taken before the first dose and 28 days after the last dose. We evaluated anti-PRP titers quantity (geometric mean antibody concentration/GMC) and seroprotection), followed by avidity and bactericidal (quality) testing. Titer and avidity of anti-PRP were tested using a modified version of the improved Phipps ELISA. Bactericidal capacity was evaluated using a Hib killing assay. Immune responses against other antigens in the vaccine were reported separately.Results One hundred five subjects in the pentavalent group and 106 subjects in the Hib monovalent group were tested for anti-PRP titers. Only 102 specimens for each group were available for bactericidal testing, due to insufficient volume for testing. Both vaccines induced similar anti-PRP titers, for GMC and seroprotection. Avidity increases were 82.9% and 76.4% in the pentavalent and Hib monovalent groups, respectively. Bactericidal activities were 94.1% and 89.2%, respectively. Both avidity and bactericidal activity were not significantly different between groups.Conclusion DTwP-HB-Hib vaccine induced anti-PRP quantity and quality comparable to those of the Hib monovalent vaccine given simultaneously with the DTwP-HB vaccine.

Co-Authors - Riyadi -, Burhan Alex Chairulfatah Alex Chairulfatah Ambrosius Purba Ambrosius Purba Amelia Harsanti Anggia Farrah Rizqiamuti, Anggia Farrah Arhana, Arhana Ari Prayitno Ari Prayitno, Ari Ariani Ariani Armijn Firman Azis, Muhammad Alamsyah Bethy S. Hernowo Burhan Burhan, Burhan Cissy B Kartasasmita Cissy B Kartasasmita Cissy B. Kartasasmita Cissy B. Kartasasmita Cissy B. Kartasasmita Dadang Hudaya Somasetia Deni K Sunjaya Dewi M.D Herawati Dewi Marhaeni Diah Herawati Dida Akhmad Gurnida Djajadiman Gatot Djelantik, I.G.G. Dominicus Husada Dwi Agustian Dwi Prasetyo Dwi Prasetyo Dwi Prasetyo Dwi Prasetyo Dwi Putra, Muhammad Gilang Dwirestuti, Ratna Dzulfikar DLH Eddy Fadlyana Eka Nurfitri, Eka Elizabeth, Monalisa Elsa Puji Setiawati Elsa Setiawati Erwina Sumartini Faisal Faisal Fanni Hanifa Farid Husin Farid Husin Farid Husin Ferriandis Harsono Firman F Wiranatakusumah Firman Fuad Wirakusumah Frisca Fazira Gaga Irawan Nugraha Gatot Irawan Sarosa Gatot Irawan Sarosa Gatot Irawan Sarosa, Gatot Irawan Gladys Gunawan Gurnida, Dida Gutama, Gutama Habibah, Minda Hadi Susiarno Hadyana Hadyana Hadyana Hadyana Hadyana Hadyana Hadyana Sukandar Hadyana Sukandar Hadyana Sukandar Hadyana Sukandar Hanifah Oswari Hanifah Oswari Hartono Gunardi Hartono Gunardi Hasan Basri Heni Haryani Herry Garna Herry Herman Hindra Irawan Satari Ieva Baniasih Akbar Irvan Afriandi Ismoedijanto Ita Susanti Iwin Sumarman Iwin Suwarman Johanes C Mose Julistio TB Djais Julitasari Sundoro Jusuf Sulaeman Effendi Jusuf Sulaeman Effendi Kartasmita, Cissy B Kevin Gunawan Lelani Reniarti Lelani Reniarti Lina H Soemara Linda Kristiani Taleumbanua Maddepunggeng, Martira Mardiah, Behesti Zahra Maria Ulfah Maringan Diapari L.T Martira Maddepunggeng Mei Neni Sitaremi Mei Neni Sitaresmi Meita Dhamayanti Meita Dhamayanti Meita Dhamayanti Meita Dhamayanti Meita Dhamayanti Meita Dhamayanti Mutiara Rahmani Nana Usnawati Nanan Sekarwana Nastiti Kaswandani Nia Fararid Askar Nina Herlina Lubis Nita Arisanti Novila Sjafri Bachtiar Novilia S Bachtiar Novilia Sjafri Bachtiar Novilia Sjafri Bachtiar Novilia Sjafri Bachtiar Novilia Sjafri Bachtiar Novilia Sjafri Bachtiar Novilia Sjafri Bachtiar Novilia Sjafri Bachtiar Novillia S Bachtiar Padmonodewo, Suminarti Ponpon Idjradinata Prasetya, Taufan Purboyo Solek Purboyo Solek R Dharmayanti Rachmat Gunadi Rachmat Gunadi Raihan Raihan Raihan Raihan, Raihan Ratih Eka Pujasari Retno Puji Astuti Rini Mulia Sari Rini Mulia Sari Rodman Tarigan Sahril, Indra Saptawati Bardosono Setyo Handryastuti Shelly Iskandar Siska Bradinda Putri Sudirman Siti Nur Fatimah Siti Nur Fatimah Sitorus, Rita Sjarif Hidajat Effendi Soedjatmiko Soedjatmiko Soedjatmiko Soenarjati Soedigo Adi Soenarjati Soedigo Adi Solek, Purboyo Sri Rejeki H Hadinegoro. Sri Rezeki Hadinegoro, Sri Rezeki Sri Rezeki S. Hadinegoro Sri Rezeki S. Hadinegoro, Sri Rezeki S. Sri Utami Suganda Tanuwidjaja Sunarjati Sudigdoadi Sunarjati Sudigdoadi Susiarno, Hadi Syafriyal Syafriyal, Syafriyal Syawitri P. Siregar Tatu Septiani Nurhikmah Tetty Yuniati Uni Gamayani, Uni Vanda Elfira Veranita Pandia Vita Murniati Tarawan Winarno, Gatot N.A Wiryawan Permadi Yogi Agustian Yuni Susanti Pratiwi Yuni Susanti Pratiwi Yunita Andriani Zakiuddin Munasir Zakiudin Munasir Zakiudin Munasir

Title

Found 51 Documents
Search

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Title Search

Found 51 Documents Search

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Title

Found 51 Documents
Search